Time Machine
Step into a future where science fiction meets reality – the world of cell and gene therapies.
Discover how cryopreservation, CRISPR, and advanced technologies are transforming lives and forging the future of medicine. Join us as industry experts explore the promises and challenges of the industry’s most cutting-edge therapies – a new adventure in disease eradication.
Sponsors
You have a vision. We have a mission.
At Eppendorf, our aim is to empower bioprocess experts in cell and gene therapy development to facilitate the translation of basic research into commercially viable applications. Our bioprocess solutions are not merely products; they are comprehensive systems that integrate instruments, software, consumables, and services to tackle the specific challenges of upstream bioprocessing. With these solutions we strive to advance cell cultivation, focusing on scalability, reproducibility, quality, time-to-market and cost-effectiveness.
We offer a range of scalable bioprocess systems, single-use bioreactors, sophisticated software solutions, and a variety of services that enhance process control, automate routine procedures, and utilize data for strategic decision-making. Partnering with Eppendorf means gaining a reliable partner committed to speeding up your bioprocess workflows, minimizing risks, and ensuring success in your CGT projects.
Since our foundation in 1945, Eppendorf has been a pioneer in scientific innovation with the mission to improve human living conditions. By partnering with Eppendorf, you gain access to cutting-edge technology and expertise that enhance the efficiency, safety, and success of your cell and gene therapy projects. Together, we can drive innovation and achieve superior outcomes in your biopharma and biotech endeavors.
Let’s bioprocess together
For more information visit: www.eppendorf.com/bioprocess
As the leading precision logistics partner of advanced therapy medicinal products (ATMPs), Marken seamlessly guides your cell and gene therapies through each stage of the biopharmaceutical logistics journey from clinical to commercial. With a global GMP-depot cryogenic network with LN2 filling stations, quality-driven systems and rigorous risk management processes, Marken ensures the safe, timely, and effective delivery of time and temp-critical therapies.
Our Advanced Therapy Division delivers specialty services such as real-time tracking, cryogenic storage, regulatory guidance, and 24/7 monitoring through our strategically located Advanced Therapy Control Towers. These state-of-the-art monitoring facilities provide full visibility of all advanced therapy shipments anywhere in the world, enabling critical-path decision making and rapid response to any potential transport risks, such as environmental, geopolitical, or economic disruption.
Marken continuously invests in advanced therapy infrastructure including our Advanced Therapy Centers of Excellence, cutting-edge technology, and agnostic packaging fleet supporting any temperature range from ambient to deep frozen, ensuring flawless execution of every ultra-sensitive shipment.
With decades of industry-leading expertise, Marken’s focus on product integrity and real-time, end-to-end monitoring through GPS and temperature loggers ensures a seamless supply chain strategy, from development to delivery. We are committed to delivering life-saving therapies to patients with uncompromised quality and efficiency.
Discover more at www.marken.com/capabilities/cell-gene-therapy/
Transforming cell and gene therapies into safe and accessible life-changing treatments is a monumental task. Each stage of development, from initial discovery to commercial success, presents unique challenges.
Benefit from high-throughput, scalable technologies and digital solutions designed to enhance productivity and support streamlined scale-up. Rely on our global network of advanced therapy experts to support your next breakthrough, and navigate a dynamic regulatory landscape as you approach clinical and commercial manufacturing.
Recent enhancements to our portfolio, including critical raw materials from CellGenix, Albumedix, and Polyplus, bring decades of expertise and innovation. These additions have supported numerous FDA and EMA approved therapies, providing a robust foundation for your own therapeutic advancements.
Simplify your path to groundbreaking cell and gene therapies with Sartorius.
We’re in this together. For better health for more people.
www.sartorius.com/inthistogether
